Dr. Joseph Schwartz, MD, MPH, professor of pathology and cell biology at Columbia University Irving Medical Center, has been selected as the recipient of the 2019 Hemphill-Jordan Leadership Award from the AABB, a professional organization dedicated to advancing the fields of transfusion medicine and cellular therapies.

Dr. Joseph Schwartz receives the 2019 Hemphill-Jordan Leadership Award at the AABB annual conference.

This award, renamed in 2005 after Bernice Hemphill, W. Quinn Jordan, and Joel Solomon, honors leaders from the transfusion medicine and cellular therapy community. The award recognizes an individual who made significant contributions in the areas of administration, quality programs, law and/or government affairs. The recipient demonstrates leadership qualities and a consistent willingness to lend expertise to peers.

As the director of the Transfusion Medicine and Cellular Therapy Unit at NewYork-Presbyterian Hospital/Columbia, Dr. Schwartz works on a daily basis to provide patients with innovative and lifesaving procedures, including depletion procedures such as leukocytapheresis and thrombocytapheresis, hematopoetic cell collection for bone marrow transplantation, extracorporeal photochemotherapy (photopheresis; ECP), and plasma exchange and RBC exchange. Among other leadership roles, Dr. Schwartz participates in the AABB Cellular Therapies Section Coordinating Committee, and his contributions have been recognized by the AABB Blood Bank/Transfusion Services and Cellular Therapy Standards’ Committees. In addition, Dr. Schwartz is a valued mentor to peers and is dedicated to teaching the next generation of leaders in transfusion medicine.

Dr. Schwartz accepted the award and gave a corresponding lecture at this year's AABB Annual Meeting, held October 19-22, 2019 in San Antonio, Texas.

Congratulations to Dr. Schwartz for receiving this prestigious award!

Read more on the AABB blog.